Name
Session III: Short Talks (Continued) & Therapeutic Targeting of Cellular Mechanisms
Date & Time
Thursday, May 21, 2026, 2:30 PM - 3:10 PM
Minhee Lee Joseph Ongkingco Adriana Di Nanni, PhD Xiaoqing Han, PhD Gideon Yawson Ruocheng Yu, PhD Madeeha Ali, PhD Andrew Paige
Description

2:30 PM

Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases
Minhee Lee, Columbia University 

2:32 PM

Development of Crosslinked Helix Dimer Protein Degraders
Joseph Ongkingco, New York University 

2:34 PM

Towards the AI-Guided Development of Novel Living-Yeast Biosensors: a Platform for the Prediction, High-throughput Synthesis, and Screening of Novel G-Protein Coupled Receptors 
Adriana Di Nanni, PhD, Columbia University 

2:36 PM

Autophagy–Lysosome Targeting Heterobifunctional Chimeras as Therapeutic Approaches 
Xiaoqing Han, PhD, Merck 

2:38 PM

Inhibiting the Folding Activity of Human Hsp70s with Selective Peptidomimetics 
Gideon Yawson, New York University 

2:40 PM

Development of Minimalistic Radical-Trapping Probes for Labeling Protein Thiyl Radicals 
Ruocheng Yu, PhD, Harvard University 

2:50 PM

Kinetic Selectivity of Kinase Inhibitors 
Madeeha Ali, PhD, Stony Brook University 

3:00 PM

Elucidation of the Mechanism-of-Action of Empirically-Isolated, Breakthrough Folding-Corrector Drugs via Cryo-EM Reconstruction of Protein Folding Intermediates 
Andrew Paige, Columbia University